LUNG

2.00

13.64% 0.24

Handel nachbörslich: 2.03 0.03 +1.50%

Pulmonx Corp (LUNG)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$1.76

Offen:

$1.76

24-Stunden-Volumen:

2.10M

Relative Volume:

0.91

Marktkapitalisierung:

$81.49M

Einnahmen:

$68.68M

Nettoeinkommen (Verlust:

$-60.84M

KGV:

-1.25

EPS:

-1.6

Netto-Cashflow:

$-38.42M

1W Leistung:

+21.95%

1M Leistung:

+23.46%

6M Leistung:

-58.59%

1J Leistung:

-68.00%

1-Tages-Spanne:

$1.74

$2.10

1-Wochen-Bereich:

$1.56

$2.89

52-Wochen-Spanne:

$1.47

$9.37

Pulmonx Corp Stock (LUNG) Company Profile

Firmenname

Pulmonx Corp

Sektor

Healthcare (1135)

Branche

Medical Devices (144)

Telefon

650-364-0400

Adresse

700 CHESAPEAKE DRIVE, REDWOOD CITY

Mitarbeiter

291

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

LUNG's Discussions on Twitter

Vergleichen Sie LUNG mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LUNG Pulmonx Corp	2.00	71.71M	68.68M	-60.84M	-38.42M	-1.60
ABT Abbott Laboratories	123.62	216.79B	43.84B	13.90B	6.78B	7.9725
BSX Boston Scientific Corp	100.72	149.02B	19.35B	2.78B	3.49B	1.8696
SYK Stryker Corp	356.24	141.06B	23.82B	2.92B	4.02B	7.5574
MDT Medtronic Plc	90.70	116.68B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	82.45	49.01B	5.69B	1.41B	577.90M	6.9828

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-31	Herabstufung	Piper Sandler	Overweight → Neutral
2025-03-10	Eingeleitet	D. Boral Capital	Buy
2024-12-11	Herabstufung	Citigroup	Buy → Neutral
2024-06-04	Eingeleitet	Lake Street	Buy
2024-02-23	Herabstufung	Wells Fargo	Overweight → Equal Weight
2023-09-05	Eingeleitet	Craig Hallum	Buy
2023-02-27	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-01-03	Herabstufung	BofA Securities	Neutral → Underperform
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-07-11	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Neutral
2021-12-08	Hochstufung	Piper Sandler	Neutral → Overweight
2021-04-01	Eingeleitet	Citigroup	Buy
2021-03-25	Eingeleitet	Piper Sandler	Neutral
2021-03-10	Hochstufung	BofA Securities	Neutral → Buy
2021-01-04	Herabstufung	BofA Securities	Buy → Neutral
2020-10-26	Eingeleitet	BofA Securities	Buy
2020-10-26	Eingeleitet	Canaccord Genuity	Buy
2020-10-26	Eingeleitet	Morgan Stanley	Equal-Weight
2020-10-26	Eingeleitet	Stifel	Buy
2020-10-26	Eingeleitet	Wells Fargo	Equal Weight

Alle ansehen

Pulmonx Corp Aktie (LUNG) Neueste Nachrichten

Oct 31, 2025

Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? - Insider Monkey

Oct 31, 2025

Is Pulmonx Corporation reversing from oversold territoryWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com

Oct 31, 2025

Historical volatility pattern of Pulmonx Corporation visualizedChart Signals & High Accuracy Swing Trade Signals - newser.com

Oct 31, 2025

Oct 29, 2025

Why Pulmonx Corporation stock remains on watchlistsJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com

Oct 29, 2025

Is this a good reentry point in Pulmonx CorporationJuly 2025 Snapshot & Daily Profit Focused Screening - newser.com

Oct 29, 2025

Pulmonx (NASDAQ:LUNG) Given New $14.00 Price Target at D. Boral Capital - MarketBeat

Oct 29, 2025

Pulmonx (LUNG) Anticipates Q3 Revenue of $21.5 Million - GuruFocus

Oct 29, 2025

What hedge fund activity signals for Pulmonx Corporation stockRecession Risk & Daily Profit Maximizing Tips - newser.com

Oct 29, 2025

Tick level data insight on Pulmonx Corporation volatilityMarket Activity Summary & Entry Point Strategy Guides - newser.com

Oct 29, 2025

Oct 28, 2025